The therapeutic window is determined through clinical trials and extensive research. Initial phases of clinical trials (Phase I and II) focus on identifying the safety profile and effective dosage range of new drugs. Researchers monitor the pharmacokinetics and pharmacodynamics of the drug, observing how it is absorbed, distributed, metabolized, and excreted by the body.
